Development of a green synchronous spectrofluorimetric technique for simultaneous determination of Montelukast sodium and Bilastine in pharmaceutical formulations

Abstract For the treatment of rhinitis and asthma, a combination of Montelukast sodium and Bilastine has just been approved. Based on the first derivative of synchronous fluorescence, the current work developed a green, highly accurate, sensitive, and selective spectroscopic approach for estimating...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Sayed M. Derayea, Khalid M. Badr El-Din, Ahmed S. Ahmed, Ahmed A. Khorshed, Mohamed Oraby
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMC 2024-01-01
Reeks:	BMC Chemistry
Onderwerpen:	Bilastine Montelukast sodium Synchronous spectrofluorimetry Pharmaceutical formulation Content uniformity
Online toegang:	https://doi.org/10.1186/s13065-024-01116-3
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!